Pan-cancer analysis reveals genomic fidelity and evolution of patient-derived organoids
Raz, L.; Ben-Yishay, T.; Khoury, H.; Saad, R.; Zoabi, A.; Orlandi, G.; Donzelli, S.; Blandino, G.; Ben-David, U.
Show abstract
Patient-derived organoids (PDOs) are gaining recognition as a promising ex vivo model for cancer research, offering advantages over traditional 2D cell lines by better recapitulating tumor biology. In this study, we assess the genomic stability and evolution of PDOs by analyzing copy-number alterations (CNAs) in 261 PDO samples across 15 cancer types. These results are compared with data from previously analyzed patient-derived xenografts (PDXs). We observe that PDOs exhibit genomic evolution over passaging, with an increasing divergence from the original tumor genome over time. Importantly, across cancer types, PDOs maintain higher genomic fidelity and are more genetically similar to their tumors of origin than PDX models. Moreover, PDOs show greater genomic stability during culture passaging compared to PDXs. These findings position PDOs as a potentially more reliable and representative model for cancer research, offering an alternative with better genomic stability for translational studies and drug testing.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The ALT pathway generates telomere fusions that can be detected in the blood of cancer patients 96%
- XENTURION, a multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients for population-level translational oncology 95%
- Reconstructing disease dynamics for mechanistic insights and clinical benefit 95%
Similar papers in this journal
- Generation of a biliary tract cancer cell line atlas reveals molecular subtypes and therapeutic targets 95%
- Single cell view of tumor microenvironment gradients in pleural mesothelioma 94%
- Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma 94%
Similar papers in this journal
- Cell cycle alterations associate with a redistribution of mutation rates across chromosomal domains in human cancers 95%
- Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome 95%
- Global loss of promoter-enhancer connectivity and rebalancing of gene expression during early colorectal cancer carcinogenesis 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.